A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

Clinical trial NCT07155668 · COMPLETED

Trial details

NCT number: NCT07155668
Sponsor: Viridian Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Thyroid Eye Disease

Start date: 2025-07-01
Primary completion: 2026-05-28
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.